Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced Cancer
| Image |  |
|---|---|
| Description | scientific article published on 16 March 2018 |
| Author/s |
author: Toshihiko Doi |
| Publication date | March 16, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |